GB914630A - Anticholinergic compositions comprising scopolamine cation-exchange resin compounds and quinazolone derivatives - Google Patents

Anticholinergic compositions comprising scopolamine cation-exchange resin compounds and quinazolone derivatives

Info

Publication number
GB914630A
GB914630A GB40553/60A GB4055360A GB914630A GB 914630 A GB914630 A GB 914630A GB 40553/60 A GB40553/60 A GB 40553/60A GB 4055360 A GB4055360 A GB 4055360A GB 914630 A GB914630 A GB 914630A
Authority
GB
United Kingdom
Prior art keywords
sulphonic acid
methyl
scopolamine
resins
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB40553/60A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Filter Wallace and Tiernan Inc
Original Assignee
Wallace and Tiernan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wallace and Tiernan Inc filed Critical Wallace and Tiernan Inc
Publication of GB914630A publication Critical patent/GB914630A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
GB40553/60A 1959-11-27 1960-11-25 Anticholinergic compositions comprising scopolamine cation-exchange resin compounds and quinazolone derivatives Expired GB914630A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85553459A 1959-11-27 1959-11-27

Publications (1)

Publication Number Publication Date
GB914630A true GB914630A (en) 1963-01-02

Family

ID=25321500

Family Applications (1)

Application Number Title Priority Date Filing Date
GB40553/60A Expired GB914630A (en) 1959-11-27 1960-11-25 Anticholinergic compositions comprising scopolamine cation-exchange resin compounds and quinazolone derivatives

Country Status (2)

Country Link
FR (1) FR925M (da)
GB (1) GB914630A (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4252790A (en) * 1974-10-23 1981-02-24 Interx Research Corporation Method for treating gastric ulcer-prone patients

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4252790A (en) * 1974-10-23 1981-02-24 Interx Research Corporation Method for treating gastric ulcer-prone patients

Also Published As

Publication number Publication date
FR925M (da) 1961-11-13

Similar Documents

Publication Publication Date Title
IL57577A0 (en) 1,2-dihydroquinolin-2-one derivatives,process for their preparation and pharmaceutical compositions containing the same
GB1099787A (en) Novel nitro-imidazole derivatives and the manufacture thereof
GB914630A (en) Anticholinergic compositions comprising scopolamine cation-exchange resin compounds and quinazolone derivatives
GB1137764A (en) Improvements in or relating to pharmacologically-active secondary amines
GB923387A (en) Plant growth inhibiting compositions
GB939901A (en) Improvements in or relating to amino pyrazoles
ATE3769T1 (de) 1-imidazol-2-yliden-3-thienyl-harnstoffderivate verfahren zu deren herstellung und pharmazeutische zusammensetzungen.
GB1504862A (en) Terpeno-phenoxyalkylamines
ES460544A1 (es) Procedimiento para la preparacion de nuevos derivados de a- cido 4-fenoxi-alfafenoxialcancarboxilico substituidos en el nucleo.
NO833529L (no) Fremgangsmaate for fremstilling av terapeutisk aktive alfa-aryl-alfa-pyridylalkansyrederivater
GB840384A (en) Improvements in or relating to hemicyanine dyestuffs
GB1043158A (en) Improvements in or relating to piperidylalkidene-5h-dibenzo(a,d)cycloheptenes
GB1124261A (en) Naphthofuran derivatives
GB1073521A (en) Indole derivatives
GB1105492A (en) Improvements in or relating to novel 3-tropanyl 2-phenylacrylate derivatives
JPS5754175A (ja) Shinkina33aminoindazoorujudotai
GB843834A (en) N-(5-nitro-2-furyl)-alkylidene-3-amino-5-tertiaryaminomethyl-2-oxazolidones and chemotherapeutic compositions containing them
US3932642A (en) Biocidal compositions containing a 2- (5'-nitro-2'-furyl)-thieno(2,3-d) pyrimidine and methods of use
GB963998A (en) Improvements in or relating to combating worm infections and pharmaceutical preparations therefor
JPS5569512A (en) Antispasmodic agent
GB976719A (en) New derivatives of heparin and processes for their preparation
ES382438A1 (es) Un procedimiento para la preparacion de una composicion farmaceutica para reducir la irritacion gastrica.
GB1199040A (en) Diisoeugenol Derivatives
GB865974A (en) Manufacture of new phenyl-quinuclidines
GB942876A (en) Improvements in or relating to piperidylidene-thiaxanthene